Mark enrolled in a clinical trial to treat peritoneal mesothelioma, a rare cancer caused by exposure to toxic asbestos When 69-year-old Mark Daly first started…
Mark enrolled in a clinical trial to treat peritoneal mesothelioma, a rare cancer caused by exposure to toxic asbestos When 69-year-old Mark Daly first started…
